52-week safety profile of ixekizumab in Asian patients with moderate-to-severe plaque psoriasis: An integrated analysis from UNCOVER-1 and IXORA-P studies
AUSTRALASIAN JOURNAL OF DERMATOLOGY（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined